Source The Telegraph: Statins could soon be prescribed to treat multiple sclerosis after a groundbreaking trial began to see if the cheap cholesterol busting drug could delay symptoms.
Statins could soon treat multiple sclerosis as ‘momentous’ trial begins Read More »
Source The Telegraph: British scientists have discovered a potential cause for multiple sclerosis, in a major breakthrough that could pave the way for new treatments for the disease.
Source BBC: Scientists hope they have found a drug to stop all neurodegenerative brain diseases, including dementia.
New drug for neurodegenerative disease is being developed Read More »
Source Multiple Sclerosis News Today: Brain stem cells from primary progressive multiple sclerosis (PPMS) patients lack the ability to repair brain damage and to trigger the maturation of protective myelin-producing cells, a surprising study with far-reaching implications indicates.
Research on Faulty Stem Cells Suggests MS Patients Need Tailored Therapies Read More »
Source Multiple Sclerosis News Today: British scientists have accelerated from weeks to days the process by which stem cells generate brain cells, which could open the door to new treatment approaches for diseases such as multiple sclerosis.
Scientists Accelerate Stem Cells’ Production of Brain Cells to Just Days, Study Reports Read More »
Source MS Society: Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US.https://www.mssociety.org.uk/ms-news/2017/03/first-treatment-licensed-primary-progressive-ms-us
First treatment licensed for primary progressive MS in the US Read More »
Source Multiple Sclerosis News Today: The potential approval of Ocrevus (ocrelizumab) this month supports the idea that, someday, a world free of multiple sclerosis (MS) is possible, according to Dr. Tim Coetzee, the National Multiple Sclerosis Society’s chief advocacy, services and research officer. While Coetzee — and the society he represents — realize the potential of Ocrevus to improve MS treatment, both also
Ocrevus and the Hope of ‘Ending MS Forever’: Interview with MS Society’s Tim Coetzee Read More »
Source pmlive.com: Biogen’s new multiple sclerosis (MS) therapy should be available to NHS patients in England within three months after NICE reversed an earlier appraisal decision.
NICE backtracks on Biogen’s multiple sclerosis drug Zinbryta Read More »
Source MS Society: NICE has approved a new affordability test for drugs, which could delay one in five new treatments becoming available on the NHS by up to 3 years.
New ‘budget impact test’ could delay access to new drugs Read More »
Source BBC: Research by scientists at Queen’s University in Belfast could revolutionise life for people with multiple sclerosis (MS).
Queen’s University multiple sclerosis research ‘a landmark’ Read More »
